Shyama Computronics and Services Ltd Stock Price Today (NSE: SHYAMACOMP)
Fundamental Score
Shyama Computronics and Services Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Shyama Computronics and Services Ltd share price today is ₹3.47, up +9.46% on NSE/BSE as of 31 July 2026. Shyama Computronics and Services Ltd (SHYAMACOMP) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹3.02 (Cr). The 52-week high for SHYAMACOMP share price is ₹5.60 and the 52-week low is ₹2.63. At a P/E ratio of 27.45x, SHYAMACOMP is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 1.08% and a debt-to-equity ratio of 0.00.
Shyama Computronics and Services Ltd Share Price Chart — NSE/BSE Historical Performance
Shyama Computronics and Services Ltd share price chart: -16.99% return over the past month. 52-week high ₹5.60, 52-week low ₹2.63.
Shyama Computronics and Services Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹3.40 | ₹3.47 | ₹3.40 | ₹3.47 | 1.20K (Cr) | |
| ₹2.96 | ₹3.17 | ₹2.96 | ₹3.17 | 3.00K (Cr) | |
| ₹3.02 | ₹3.02 | ₹3.02 | ₹3.02 | 3.30K (Cr) | |
| ₹2.88 | ₹2.88 | ₹2.88 | ₹2.88 | 800.00 (Cr) | |
| ₹2.76 | ₹2.76 | ₹2.63 | ₹2.63 | 4.60K (Cr) | |
| ₹2.78 | ₹2.78 | ₹2.76 | ₹2.76 | 6.60K (Cr) | |
| ₹2.88 | ₹2.90 | ₹2.88 | ₹2.90 | 900.00 (Cr) | |
| ₹3.00 | ₹3.00 | ₹3.00 | ₹3.00 | 0.00 (Cr) | |
| ₹3.00 | ₹3.00 | ₹3.00 | ₹3.00 | 0.00 (Cr) | |
| ₹3.00 | ₹3.00 | ₹3.00 | ₹3.00 | 0.00 (Cr) |
Shyama Computronics and Services Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹4.18 | ₹4.18 | ₹2.63 | ₹3.47 | -16.99% | |
| ₹3.63 | ₹5.55 | ₹3.63 | ₹4.39 | +20.94% | |
| ₹3.00 | ₹3.63 | ₹2.85 | ₹3.63 | +21.00% | |
| ₹3.00 | ₹3.00 | ₹2.90 | ₹2.90 | -3.33% | |
| ₹3.80 | ₹3.80 | ₹2.99 | ₹3.00 | -21.05% | |
| ₹4.00 | ₹4.30 | ₹3.71 | ₹3.80 | -5.00% | |
| ₹5.14 | ₹5.14 | ₹4.21 | ₹4.21 | -18.09% | |
| ₹4.90 | ₹4.90 | ₹4.90 | ₹4.90 | +0.00% | |
| ₹5.06 | ₹5.06 | ₹4.35 | ₹4.90 | -3.16% | |
| ₹5.50 | ₹5.60 | ₹5.32 | ₹5.32 | -3.27% | |
| ₹5.30 | ₹5.56 | ₹5.30 | ₹5.50 | +3.77% | |
| ₹5.50 | ₹5.50 | ₹5.30 | ₹5.30 | -3.64% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Shyama Computronics and Services Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Shyama Computronics and Services Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SHYAMACOMP across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Attractive Valuation (P/E: 27.45 vs Industry: 34.89)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (13.30% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (1.08%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (1.47%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-92.31%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Profit Decline Concern (-77.78%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-14.29%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Negative Free Cash Flow (₹-2.54 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (0.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Shyama Computronics and Services Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Shyama Computronics and Services Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Shyama Computronics and Services LtdShyama Computro...Selected✓ SHYAMACOMP • 531219 | 14.4/100 | ₹3.47₹3 | ₹3.02₹3.02 | 27.45Average 27.4 Average | 1.08%Poor 1.08% Poor | 1.47%Poor 1.47% Poor | 0.00Excellent 0.0 Excellent | 6.58%Good 6.58% Good | 13.30%Good 13.30% Good | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1990.50₹1991 | ₹468821.49₹468821.49 | 37.73Average 37.7 Average | 15.95%Good 15.95% Good | 20.53%Excellent 20.53% Excellent | 0.06Excellent 0.1 Excellent | 16.75%Excellent 16.75% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 56.3/100 | ₹8056.00₹8056 | ₹193163.97₹193163.97 | 73.64Average 73.6 Average | 16.53%Good 16.53% Good | 21.96%Excellent 21.96% Excellent | 0.00Excellent 0.0 Excellent | 5.71%Good 5.71% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹5122.80₹5123 | ₹169902.02₹169902.02 | 77.52Average 77.5 Average | 27.43%Excellent 27.43% Excellent | 15.19%Good 15.19% Good | 1.79Average 1.8 Average | 12.07%Good 12.07% Good | 11.80%Good 11.80% Good | 0.76% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 40.2/100 | ₹1473.20₹1473 | ₹116131.81₹116131.81 | 30.51Average 30.5 Average | 11.60%Average 11.60% Average | 15.49%Good 15.49% Good | 0.02Excellent 0.0 Excellent | 9.94%Good 9.94% Good | 8.01%Good 8.01% Good | 0.90% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1078.30₹1078 | ₹115375.77₹115375.77 | 21.26Average 21.3 Average | 21.25%Excellent 21.25% Excellent | 21.14%Excellent 21.14% Excellent | 0.46Excellent 0.5 Excellent | 18.77%Excellent 18.77% Excellent | 12.45%Good 12.45% Good | 0.09% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 83.4/100 | ₹2415.00₹2415 | ₹113976.53₹113976.53 | 20.04Average 20.0 Average | 28.68%Excellent 28.68% Excellent | 29.93%Excellent 29.93% Excellent | 0.29Excellent 0.3 Excellent | 37.02%Excellent 37.02% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2469.60₹2470 | ₹105053.91₹105053.91 | 52.29Average 52.3 Average | 13.12%Average 13.12% Average | 13.50%Average 13.50% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 41/100 | ₹1148.10₹1148 | ₹102660.46₹102660.46 | 25.62Average 25.6 Average | 11.22%Average 11.22% Average | 13.04%Average 13.04% Average | 0.20Excellent 0.2 Excellent | 15.44%Excellent 15.44% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1580.20₹1580 | ₹90035.87₹90035.87 | 25.38Average 25.4 Average | 10.06%Average 10.06% Average | 12.80%Average 12.80% Average | 0.21Excellent 0.2 Excellent | 0.80%Average 0.80% Average | 6.32%Good 6.32% Good | 0.26% |
Laurus Labs LtdLaurus Labs Ltd... LAURUSLABS • 540222 | 34.1/100 | ₹1816.20₹1816 | ₹84016.75₹84016.75 | 93.94Average 93.9 Average | 18.30%Good 18.30% Good | 17.76%Good 17.76% Good | 0.48Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price468821.49 Cr
- Divis Laboratories Ltd share price193163.97 Cr
- Torrent Pharmaceuticals Ltd share price169902.02 Cr
- Cipla Ltd share price116131.81 Cr
- Zydus Lifesciences Ltd share price115375.77 Cr
Shyama Computronics and Services Ltd Quarterly Performance
Latest quarterly metrics for SHYAMACOMP — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-14.29%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-77.78%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
13.30%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
6.58%
Compounded annual net profit growth over 5 years
Shyama Computronics and Services Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SHYAMACOMP — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Shyama Computronics and Services Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Shyama Computronics and Services Ltd (SHYAMACOMP) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Shyama Computronics and Services Ltd
About SHYAMACOMP (Shyama Computronics and Services Ltd)
Shyama Computronics and Services Ltd is a pioneering force driving digital transformation within the pharmaceutical sector. We specialize in crafting bespoke IT solutions meticulou...sly tailored to address the unique demands of pharmaceutical research, manufacturing, and distribution. Our focus lies in empowering pharmaceutical companies to streamline operations, accelerate drug discovery, and ensure regulatory compliance through cutting-edge technology. We understand the critical importance of data security and integrity in the pharmaceutical landscape, thus offering robust solutions that safeguard sensitive information and maintain the highest standards of quality. At SHYAMACOMP, we offer a comprehensive suite of services designed to cover every facet of the pharmaceutical IT ecosystem. From developing advanced laboratory information management systems (LIMS) and electronic data capture (EDC) tools to implementing sophisticated supply chain management solutions, we provide end-to-end support. We leverage the power of artificial intelligence and machine learning to enhance drug development processes, optimize clinical trials, and personalize patient care. Our team of experienced IT professionals collaborates closely with pharmaceutical experts to deliver solutions that are not only technologically advanced but also deeply rooted in industry best practices. We are committed to being a trusted partner in the pharmaceutical industry's journey toward digital excellence. SHYAMACOMP helps pharmaceutical organizations navigate the complexities of a rapidly evolving technological landscape. We help them achieve operational efficiency, improve patient outcomes, and gain a competitive edge in the global market. Our unwavering dedication to innovation and customer satisfaction allows us to provide our clients with superior IT solutions that drive tangible business results. Shyama Computronics and Services Ltd stands as a beacon of technological advancement for pharmaceuticals.
Company Details
Key Leadership
SHYAMACOMP Share Price: Frequently Asked Questions
What is the current share price of Shyama Computronics and Services Ltd?
Shyama Computronics and Services Ltd (SHYAMACOMP) trades at ₹3.47 on NSE and BSE. Market cap ₹3.02 (Cr). Educational data only.
What is the P/E ratio of Shyama Computronics and Services Ltd?
Shyama Computronics and Services Ltd has a P/E of 27.45x vs industry average 34.89x.
What is the Bull Run score for Shyama Computronics and Services Ltd?
Shyama Computronics and Services Ltd has a Bull Run score of 14.4/100 based on 25+ financial parameters.
Does Shyama Computronics and Services Ltd pay dividends?
Shyama Computronics and Services Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Shyama Computronics and Services Ltd?
Shyama Computronics and Services Ltd has ROE of 1.08%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Shyama Computronics and Services Ltd?
Shyama Computronics and Services Ltd has debt-to-equity of 0.00.
Is Shyama Computronics and Services Ltd a good investment?
Bull Run gives Shyama Computronics and Services Ltd a score of 14.4/100. This is not investment advice — consult a SEBI-registered advisor.